Beijing, China · Founded 2019 · Privately Held (backing)
Provider of CDMO process development and GMP production services for cell culture, bioprocessing, and biologics-related technical applications. BioInno is based in Beijing, China and was founded in 2019. Its last reported valuation was $156 million in Dec 2021. It has raised $48.1 million.
Last reported valuation
$156.4M
Oct 2026
Priced at
—
Total raised
$48.1M
Last round
—
Team — not yet on record
No current team members for BioInno are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of BioInno with a free account
·The complete investor list: 13 names
·Watch BioInno: the Monday email on marks, rounds and moves
